Back to Screener

Quantum X Labs Inc. - Common Stock (QXL)

NASDAQ Micro Cap
$6.35
Market Cap: $137M
Data as of Jun 30, 2026 (TTM)

Price History

May 6, 2026 — Aug 21, 2026

Investment Snapshot

  • P/B of 5.31 — trading above book value
  • Piotroski F-Score 4/9 — moderate financial health
  • Loss-making — negative ROE of -51.1%
  • Revenue declining 66% annually

Quantum X Labs Inc. - Common Stock (QXL) is a publicly traded company, listed on the NASDAQ , with a market capitalisation of $137 million . Key value metrics: P/B ratio 5.31, Piotroski F-Score 4 out of 9 (moderate financial health) .

Value Score

Key Metrics

P/E Ratio
5.31
EPS
$-0.61
Div. Yield
PEG Ratio
P/S Ratio
EV/EBITDA
ROE
ROA
Gross Margin
Op. Margin
Net Margin
Debt/Equity
Current Ratio
Data sourced from SEC EDGAR and Polygon.io. Methodology.

Quantum X Labs Inc. - Common Stock — Fundamental Analysis Summary

On financial health, QXL shows a moderate Piotroski F-Score of 4/9, and negative return on equity of -51.1%, and minimal leverage with a debt-to-equity ratio of 0.02.

StockPik's composite Value Score for QXL is 25/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.

QXL shows revenue declining at 66% year-over-year, with earnings declining at 60%.

How is the Value Score calculated?
Read our full methodology →
What is the Piotroski F-Score?
The 9-point financial health score explained, with worked examples →
Previous
QVCGA
Next
QXO